120
Participants
Start Date
April 1, 2021
Primary Completion Date
April 30, 2024
Study Completion Date
November 30, 2024
Group 1: Miltefosine
Miltefosine 50 mg pill will be administered po every 8 hours with food, during 28 days
Group 2: Pentavalent Antimony
will be administered by IV infusion diluted in 150 ml of DWD5% over 20 minutes
Group 3: Liposomal amphotericin B
3 amps (150 mg) will be administered by IV infusion iver 2 hours every other day for a total of 15 doses.
RECRUITING
Hospital Dermatologico de Jorochito, Santa Cruz de la Sierra
Hospital Dermatologico de Jorochito
UNKNOWN
Centro Nacional de Enfermedades Tropicales CENETROP
UNKNOWN
ABF Foundation for Medical Research
UNKNOWN
Fundacion Nacional de Dermatologia
OTHER